Showing results (51-60 of 114) with videos related to
Sort By:
Pageof 12
Cancers|September 23, 2022
Targeting Mutant p53 for Cancer Treatment: Moving Closer to Clinical Use?Michael J Duffy, Minhong Tang, Subhasree Rajaram, et al.Thrombosis and Haemostasis|April 2, 2003
The ADAMs family of proteins: from basic studies to potential clinical applicationsMichael J Duffy, David J Lynn, Andrew T Lloyd, et al.Clinical Chemistry|November 10, 2010
Intracellular and extracellular microRNAs in breast cancerClaire Corcoran, Anne M Friel, Michael J Duffy, et al.Critical Reviews in Oncology/Hematology|March 23, 2017
Vitamin D analogues: Potential use in cancer treatmentMichael J Duffy, Alyson Murray, Naoise C Synnott, et al.Breast Cancer Research : BCR|February 14, 2015
uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studiesMichael J Duffy, Patricia M McGowan, Nadia Harbeck, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 15, 2010
The role of S100 genes in breast cancer progressionEadaoin McKiernan, Enda W McDermott, Dennis Evoy, et al.Translational Oncology|June 13, 2024
Targeting mutant p53 with arsenic trioxide: A preclinical study focusing on triple negative breast cancerSubhasree Rajaram, Naoise C Synnott, John Crown, et al.Journal of Agricultural and Food Chemistry|May 29, 2003
Metsulfuron methyl sorption-desorption in field-moist soilsTomas Berglöf, William C Koskinen, Michael J Duffy, et al.Journal of Wildlife Diseases|September 20, 2002
Increased prevalence of Brucella suis and pseudorabies virus antibodies in adults of an isolated feral swine population in coastal South CarolinaCory S Gresham, Charles A Gresham, Michael J Duffy, et al.Cancer Letters|February 6, 2007
Survivin: a promising tumor biomarkerMichael J Duffy, Norma O'Donovan, Donal J Brennan, et al.Pageof 12